- Home
- CLPR vs VNRX Comparison
CLPR vs VNRX Comparison
Compare CLPR & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLPR | VNRX |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.6M | 38.2M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | CLPR | VNRX |
|---|---|---|
| Price | $3.42 | $0.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.17 |
| AVG Volume (30 Days) | 70.1K | ★ 2.8M |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | ★ 10.98% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $154,179,000.00 | $1,472,007.00 |
| Revenue This Year | N/A | $55.33 |
| Revenue Next Year | N/A | $493.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 5.90 | ★ 14.48 |
| 52 Week Low | $3.37 | $0.27 |
| 52 Week High | $6.49 | $0.94 |
Technical Indicators
Market Signals| Indicator | CLPR | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 37.68 | 31.94 |
| Support Level | $3.38 | $0.28 |
| Resistance Level | $3.55 | $0.31 |
| Average True Range (ATR) | 0.12 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 4.44 | 3.40 |
Price Performance
Historical ComparisonAbout CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.